{{Rsnum
|rsid=875033
|Chromosome=6
|position=67617137
|Orientation=minus
|GMAF=0.354
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 43.8 | 44.6 | 11.6
| HCB | 62.2 | 34.1 | 3.7
| JPT | 62.2 | 36.0 | 1.8
| YRI | 30.3 | 42.3 | 27.5
| ASW | 31.6 | 52.6 | 15.8
| CHB | 62.2 | 34.1 | 3.7
| CHD | 62.0 | 26.9 | 11.1
| GIH | 36.7 | 42.9 | 20.4
| LWK | 28.0 | 53.3 | 18.7
| MEX | 40.4 | 40.4 | 19.3
| MKK | 17.5 | 41.6 | 40.9
| TSI | 44.6 | 43.6 | 11.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=8E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}